Background: Studies examining the association of anogenital distance (AGD), a biomarker of prenatal androgen exposure, with sexual development in children are lacking. Objective: To assess the association between AGD measures and reproductive outcomes, including puberty onset, testicular volume, reproductive hormone levels, and urogenital malformations in boys aged 9-11 years. Materials and methods: A cross-sectional study was conducted among children belonging to the Spanish Environment and Childhood (INMA) Project, a population-based birth cohort study. The present sample included 279 boys for whom data were available on AGD, pubertal stage, testicular volume, and relevant covariates. Out of the boys with AGD data, 187 provided a blood sample for hormone analysis. AGD was measured from the center of the anus to the base of the scrotum. Pubertal development was assessed according to Tanner stage of genital development (G1-G5), and testicular volume was measured with an orchidometer. Results: After adjusting for potential confounders, logistic regression analysis showed that AGD was positively associated with testicular volume but not with Tanner stage (>G1 vs. G1), serum hormone levels, or undescended testis. Regardless of their age, body mass index, and Tanner stage (G1 or >G1), boys with longer AGD showed increased odds of a testicular volume >3 mL (OR = 1.06, 95%CI = 1.00-1.19 per 10% increment in AGD; and OR = 3.14, 95%CI = 0.99-9.94 for AGD >42 mm vs. <33 mm). Discussion: Longer AGD was associated with testicular growth, an indicator of gonadarche, but not with other reproductive outcomes. Conclusions: Although AGD was positively associated with testicular volume, it remains unclear whether AGD predicts testis size at puberty or is related to puberty onset.
INTRODUCTION
Anogenital distance (AGD), the distance from the center of the anus to the genital tubercle, is sexually dimorphic in many mammals, with a longer mean AGD in males than in females (Dean & Sharpe, 2013; Barrett et al., 2014; Adibi et al., 2015) . In rodents, AGD is a reliable biomarker of prenatal androgen and antiandrogren exposure and the associated testicular dysgenesis syndrome (TDS) Welsh et al., 2008; Macleod et al., 2010; van den Driesche et al., 2011) . The TDS hypothesis supports the concept that hypospadias, cryptorchidism, reduced semen quality, and testicular germ cell tumors may result from the disruption of fetal programming and gonadal development by intrauterine exposure to hormonally active chemicals (Wohlfahrt-Veje et al., 2009) . In line with this hypothesis, both animal and human studies have shown that prenatal exposure to a variety of chemicals with potential endocrine-disrupting activity is associated with a shorter AGD and reproductive tract anomalies in males at birth (Wolf et al., 1999; Barlow et al., 2004; Swan et al., 2005; Longnecker et al., 2007; Suzuki et al., 2012) . Specifically, epidemiological studies published over the past few years have suggested that prenatal exposure to antiandrogenic compounds, such as phthalates, dioxins, and bisphenol A, may be associated with shortened AGD in children (BustamanteMontes et al., 2013; Miao et al., 2011; Papadopoulou et al., 2013; Swan, 2008; Swan et al., 2005; Vafeiadi et al., 2013) . More recently, a shorter AGD has also been associated with the intake of certain analgesics during pregnancy (Fisher et al., 2016; Lind et al., 2017) .
As a marker of early gonadal development disruption, AGD has been examined in relation to adverse reproductive outcomes in adult men. Thus, several studies in groups of volunteers or men attending andrology clinics have published evidence linking shorter AGD with worse sperm quality (Mendiola et al., 2011 (Mendiola et al., , 2015 Eisenberg & Lipshultz, 2015) , reduced fertility (Eisenberg et al., 2011) , azoospermia (Eisenberg et al., 2012b) , and lower testosterone and estradiol levels (Eisenberg et al., 2012a; Zhou et al., 2016) . In adults, a shorter AGD has been also related to the risk of prostate cancer (Castaño-Vinyals et al., 2012) , while in male human fetuses, newborns, and infants, it has been associated with hypospadias, cryptorchidism, micropenis, and reduced thyroid hormone levels (Hsieh et al., 2008 (Hsieh et al., , 2012 Jain & Singal, 2013; Thankamony et al., 2014; Liu et al., 2016; Gilboa et al., 2017) .
Birth cohort studies in UK, Greece, and Spain have observed a rapid increase in AGD during the first 3 months of life, reaching a plateau after 1 year of age (Thankamony et al., 2009; Papadopoulou et al., 2013) . During adulthood, the AGD of men remains constant irrespective of age (Eisenberg et al., 2013; Thankamony et al., 2016) . There is a lack of longitudinal data on AGD measurements from infancy to adulthood, but it is presumed that AGD markedly increases during puberty in association with development of the external genitalia and changes in body composition . In rodents, AGD is used to determine pubertal onset because it depends on activation of the hypothalamic-pituitary-gonadal (HPG) axis by gonadal testosterone (Divall et al., 2010; Quaynor et al., 2015) . However, there has been no research on the association of AGD with the sexual development of children. With this background, the aim of this study was to assess the association between AGD measures and reproductive outcomes, including genital maturity status, reproductive hormone levels, and urogenital malformations in boys aged 9 to 11 years.
MATERIALS AND METHODS

Study population
Participants were selected from the Environment and Childhood (INMA) Project, a multicenter population-based birth cohort study designed to investigate the effect of environmental exposures and diet during pregnancy on fetal and child development in different geographic areas of Spain (http://www.proyec toinma.org). The present cross-sectional study included boys from the INMA birth cohort established in the province of Granada, southern Spain, at their follow-up visit when aged 9-11 years. The INMA-Granada birth cohort was recruited after delivery at the San Cecilio University Hospital of Granada. All eligible women who gave birth to a boy at the hospital between October 2000 and July 2002 (a total of 1741 women) were invited to participate in the INMA Project. The baseline cohort comprised 668 mother-son pairs (40% of the total invited women) and had the initial aim of investigating the association between prenatal exposure to endocrine-disrupting chemicals and urogenital malformations (cryptorchidism and hypospadias) in boys (Fernandez et al., 2007) . All recruited mothers were of Caucasian origin. The inclusion and exclusion criteria were previously published (Fernandez et al., 2007) .
A random sample of boys in the INMA-Granada cohort were recontacted and asked to participate in follow-up visits at the ages of 4-5 years (N = 220) and 9-11 years (N = 300). The follow-up of the children at the age of 9-11 years (during 2010-2012) included interview-administered questionnaires, physical examination, neuropsychological assessment, and biological sample collection (P erez-Lobato et al., 2015) . A total of 300 boys and their parents from the original cohort (45%) participated in this visit. This study included 279 boys for whom data were available on AGD, pubertal development, and relevant covariates at the age of 9-11 years. Among the boys with AGD data, only 187 provided a blood sample for hormone analysis. Informed consent was obtained from all parents or legal guardians, and the study protocol was approved by the Ethics Committee of San Cecilio University Hospital.
Physical examination
At their follow-up visit, the boys underwent a physical examination that included anthropometry, genital measurements, and Tanner stages of genital development. Physical examinations were conducted by two trained physicians (OOH and CDA) following standardized protocols. All examinations were performed in warm conditions (room temperature 20-24°C Boys were evaluated for Tanner stages of genital development and testicular volume by visual inspection. Physicians classified the appearance of external genitalia on a scale ranging from G1 (undeveloped) to G5 (fully developed): In genital stage G1, penis, testes, and scrotum are unchanged compared to early childhood; in stage G2, the scrotum and testes enlarge, the scrotum sac reddens and changes in texture, and there is little to no enlargement of the penis; in stage G3, there is further growth of the testes and scrotum and the penis begins to enlarge, mainly in length; in stage G4, the testes and scrotum continue to enlarge, the scrotal skin continues to darken, and the penis continues to grow in breadth and length; and in stage 5, the genitalia are of adult size and shape (Herman-Giddens et al., 2001) . Right and left testis volumes (in mL) were measured using the Prader orchidometer (Andrology Australia, Clayton, Victoria, Australia). In case of discrepancy between right and left testicles, the larger measurement was used for the analysis, although a difference in volume was only observed in one boy.
We used a 0.01 mm vernier caliper to measure the AGD from the center of the anus to the most posterior mid-point of the perineoscrotal junction (i.e., ano-scrotal distance), as described by Salazar-Martinez et al. (2004) . Both AGD and testicular volume measurements were performed with the child in lithotomy position with thighs at 45°to the examination table. In a randomly selected sample of 10 boys, AGD measurements were made in each boy independently by two researchers at different sessions to ensure data quality.
Boys were also examined for reproductive urogenital tract abnormalities, specifically the presence of hypospadias (a congenital anomaly in which the urethra opens onto the ventral aspect of the penis rather than at the tip) and cryptorchidism. Examinations were made with the child in supine position. Testicular position was recorded after manipulation of the testis to the most distal position along the pathway of normal descent using firm traction. Information on the presence of cryptorchidism and/or hypospadias at birth was further explored in this study. The examination technique and definition of cryptorchidism and hypospadias at birth have been previously described (Fernandez et al., 2007; Arrebola et al., 2015) .
Serum hormone analysis
Within 1-3 days of the follow-up visit, fasting morning blood samples were drawn between 8 and 9 am from 187 boys at San Cecilio University Hospital in accordance with recommendations of the hospital healthcare professionals. Serum levels of total testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) were measured by electrochemiluminescence immunoassay (Elecsys System, Roche Diagnostics GmbH, Mannheim, Germany) at the Analytical Unit of the hospital. The limit of detection (LOD) was 0.087 nmol/L for total testosterone, 0.30 mIU/mL for FSH, and 0.10 mUI/mL for LH. Concentrations of thyroid-stimulating hormone (TSH) and free thyroxin (FT4) were also measured in serum by chemiluminescence assay (Eclecsys System, Roche Diagnostics). The LOD was 0.005 mIU/ L for TSH and 0.296 pmol/L for FT4. The reference range criteria proposed for children (6-11 years) by the Manual of Reference Intervals for Children and Adults (http://www.katrangilab.org/ UploadFolder/Files/Thyroid%20Reference%20data%20Roche. pdf) are 0.60-4.84 mIU/L for TSH and 12.48-21.50 pmol/L for FT4.
Covariates
All information on potential confounding variables was obtained by questionnaire completion by the mothers after delivery and during the follow-up of the children. Maternal covariates obtained from the questionnaires and used as potential confounders in this study were as follows: age at delivery; education level at delivery, categorized as primary, secondary, or university education; maternal smoking during pregnancy (yes/ never); and place of residence during pregnancy, classified as urban (capital city of Granada), suburban (towns with >10,000 inhabitants), or rural (towns and villages with ≤10,000 inhabitants). Pre-pregnancy BMI was obtained by dividing selfreported pre-pregnancy weight in kg by current height in meters squared and was grouped as underweight/eutrophic (<25 kg/m 2 ), overweight (25-29 kg/m 2 ), or obese (≥30 kg/m 2 ). Covariate assessment also included: child's age in months; child's height, weight, and BMI; examiner (OOH or CDA); season of blood sampling (winter vs. spring, summer, or fall); child's current passive smoking (current passive smoker vs. not passive smoker); and duration of breastfeeding, categorized as 0, >0-5, or ≥6 months.
Statistical analysis
Inter-and intraexaminer variability in AGD measurements was assessed by calculating the intraclass correlation coefficient (ICC) from repeated measures in 10 boys. The ICC was 0.98, indicating excellent reliability of the AGD measurements.
Nonetheless, the 'examiner' variable was tested for confounding in all multivariate regression analyses. Puberty status was categorized into Tanner stage G1 or >G1 (G2+G3), as only two children were in Tanner stage G3. Tanner stage 1 represents nonpuberty and higher stages indicate puberty (Herman-Giddens et al., 2001; Ferguson et al., 2014) . Testis volume was grouped into ≤3 mL or >3 mL, with the latter indicating gonadarche (Mouritsen et al., 2013) .
Around one-third of the boys with available information on serum reproductive hormones (N = 55, 34%) had a testosterone level of 0.10 nmol/L and one boy had a value below the LOD. Hence, the testosterone level was classified using a cutoff point of 0.10 nmol/L. A cutoff point of 1.74 nmol/L was also used as an indicator of male sexual maturation, as in previous studies (Rapkin et al., 2006; Lopez-Espinosa et al., 2011) . In addition, serum testosterone was grouped into <1.74 nmol/L (<0.50 ng/ mL), which may indicate pre-puberty, 1.74-5.21 nmol/L (0.50-1.50 ng/mL), indicative of early puberty, or >5.21 nmol/L (>1.50 ng/mL), indicative of overt puberty, according to a previous study among 5-to 15-year-old Spanish children (GarciaMayor et al., 1997) . The remaining serum hormone levels showed skewed distributions and were therefore transformed into their natural logarithm before regression analyses. Additionally, TSH and FT4 were categorized according to the upper reference values (i.e., 4.84 mIU/L for TSH and 21.5 pmol/L for FT4). Descriptive data are shown as absolute and relative frequencies, means, SDs, medians, and interquartile ranges. We calculated the median AGD as a function of the characteristics of the boys and the outcome variables and used a nonparametric test to assess the difference in measurements between groups.
Associations of covariates with the AGD were examined by univariate linear regression analysis, and those showing a significant association at p < 0.20 entered a multivariate regression model to identify the predictors (p < 0.05) of AGD measurements. Both crude and adjusted logistic regression models were created to assess the association of AGD with Tanner stage (>G1 vs. G1), testicular volume (>3 vs. ≤3 mL), cryptorchidism at birth and at follow-up, and serum testosterone level (>0.10 vs. ≤0.10 nmol/L and ≥1.74 vs. <1.74 nmol/L). Associations with continuous LH and FSH serum levels were explored by linear regression. In adjusted models, child's BMI z-score (continuous), and current passive smoking (both found to be predictors of AGD), and child's age were included as covariates. Because of the strong associations between puberty development, testis size, and reproductive hormone levels, testicular volume and hormone level models were also adjusted for Tanner stage. Hormone level models were further adjusted for the season of blood sampling. The 10% change-in-estimate criterion was used to select additional confounders for each outcome, retaining variables in the final model if they modified the effect of AGD on outcome (b regression coefficient) by >10%. Results for logistic regression models are reported as the odds of outcome for each 10% increase in AGD. Associations of AGD with testis volume and hormone levels were also explored considering only prepubertal boys (Tanner stage G1).
In order to assess nonlinear associations between AGD and reproductive parameters, further regression analyses were conducted categorizing AGD according to tertile values, and the likelihood ratio test was performed to test the significance of linear trends across tertiles of AGD measurements. As a sensitivity 876 Andrology, 2018, 6, 874-881 analysis, we finally examined all associations by excluding outliers (>1.5 9 interquartile range) in AGD and LH and FSH levels. There were four outliers in AGD data, 11 outliers in LH, and five outliers in FSH levels. The level of significance was set at 0.05, and SPSS 23.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. Table 1 summarizes characteristics of the boys under study. Their mean age was 9 years and 11 months, 51% were overweight or obese, 15% were not breastfed, 73% were passive smokers, and 21% were prenatally exposed to tobacco smoke. Approximately 36% of the mothers were overweight or obese before pregnancy, 24% resided in urban areas during pregnancy, and 47% had a low educational level at delivery.
RESULTS
AGD data were non-normally distributed, ranging from 3 to 88 mm with a median distance of 38 mm. The boys were predominantly in Tanner stage G1 (80%) and had a testicular volume ≤3 mL (87%). The prevalence of cryptorchidism and hypospadias at this follow-up was 1.8% and 0.7%, respectively. At birth, 15 (5.4%) of the boys in the present sample had cryptorchidism and one (0.3%) had hypospadias (Table 2 ). There was a partial disagreement between increased testicular volume and Tanner stage: 20% of the boys with a testicular volume >3 mL were classified in Tanner stage G1. Only eight of the 161 boys with data on serum hormone levels had a testosterone concentration ≥1.74 nmol/L; of these eight boys, only three were in Tanner stage >G1 and two had a testicular volume >3 mL. In the global sample, 12% and 1%, respectively, had TSH and FT4 levels above upper reference values. No statistically significant difference in AGD was found between boys in Tanner stage G1 and those in higher stages or between those with and without cryptorchidism at birth or at this follow-up; however, the AGD was significantly longer in children with testis volume >3 mL (median = 45 mm) than in those with volume ≤3 mL (median = 38 mm) (p-value = 0.04).
Covariates with p-values<0.20 in the univariate regression analysis for AGD were child's weight, height, BMI z-score, and current passive smoking; and maternal smoking during pregnancy, pre-pregnancy BMI, and place of residence during pregnancy (Table 3 ). In the multivariate model, child's BMI z-score and current passive smoking remained significantly associated (p < 0.05) with AGD. On average, AGD was 4.90 mm (95% confidence interval [CI] = 1.36-8.44) and 5.15 mm (95%CI = 1.63-8.68) longer in overweight/obese vs. underweight/eutrophic boys, respectively, and was 3.91 mm (95%CI = 0.66-7.15) longer among current passive smokers than among the boys who were not.
In the multivariate regression analysis, AGD was positively associated with testicular size, with a 6% rise in the odds of (Table 4) , and a 3.14-fold higher odds (95%CI = 0.99-9.94) of increased testicular volume for boys with AGD >42 mm vs. < 33 mm, showing a significant positive linear trend across AGD tertiles (p for trend<0.001) ( Table 5 ). In contrast, no significant association was observed between continuous or categorical AGD and Tanner stage, cryptorchidism, or serum hormone levels (Tables 4  and 5 ; data not shown for hormone levels). Regression analysis considering only boys in Tanner stage G1 (N = 222) showed no association of AGD with increased testicular volume (OR = 0.92, 95%CI = 0.80-1.04) or serum hormone levels (data not shown). No substantive differences in linear or logistic regression analysis results were found between the inclusion and exclusion of outliers in AGD and hormone levels.
DISCUSSION
In this cross-sectional study of boys aged 9-11 years, the AGD was positively associated with increased testicular volume, an indicator of gonadarche, but not with Tanner stage >G1, serum levels of reproductive hormones, or cryptorchidism. After controlling for child's age, BMI, Tanner stage, and current passive smoking, longer AGD was associated with greater odds of a testicular volume >3 mL. Because the AGD may change with body growth until adulthood, it cannot be ruled out that the association observed with testicular volume is due to the increase in AGD that accompanies the increase in linear growth at puberty. Furthermore, stages of genital maturity were not graded separately from pubic hair growth. While genital development is associated with HPG axis activation and increased gonadal production of androgens, pubic hair growth is most commonly caused by the activation of adrenal androgen production (i.e., adrenarche). Hence, the lack of association with Tanner stage may be because the boys in Tanner stage >G1 were likely to have been a mixture of boys who had and had not reached adrenarche, given that the AGD reflects activation of the HPG axis but not adrenarche onset (Divall et al., 2010) .
Although conclusions on a relationship between AGD and puberty timing cannot be drawn from our findings, they suggest that AGD may predict testis size at puberty. This is a plausible proposition, given that testicular volume is a classic indicator of androgenicity (Ross et al., 2005) and murine studies have demonstrated a significant reduction in AGD after prenatal exposure to antiandrogenic chemicals and a correlation between AGD and testis size in early puberty Macleod et al., 2010) . In particular, Macleod et al. (2010) found that prenatal exposure to the known antiandrogens dibutyl phthalate and flutamide reduced AGD, testicular volume, and penile length at early puberty in male rats, and they also observed a strong correlation between pubertal AGD and testicular volume. These animal studies support the hypothesis that changes in fetal androgen exposure may impact genital size at puberty. In humans, Eisenberg et al. (2011) found that AGD was strongly correlated with testicular volume in adults attending a fertility clinic, which is in agreement with the present results, but no published study has addressed AGD and genital size in children.
In the present study, AGD measurements (mean = 38 mm, 25-75th percentile = 30-45 mm) were at the lower end of the range (38-51 mm) described for young and middle-aged men (≥18 years old) in the USA, Spain, and China (Eisenberg et al., 2011 (Eisenberg et al., , 2013 Mendiola et al., 2011 Mendiola et al., , 2015 Eisenberg & Lipshultz, 2015; Parra et al., 2016; Zhou et al., 2016) . Reports on AGD length in male newborns and children under 3 years of age have ranged from 20 to 37 mm (Salazar-Martinez et al., 2004; Swan et al., 2005; Thankamony et al., 2009; Jensen et al., 2016) . The BMI of the present boys proved to be significant predictor of AGD, as previously reported for male infants (Thankamony et al., 2009) and adults (Mendiola et al., 2011; Zhou et al., 2016) . Maternal age and in utero exposure to cigarette smoke have been also associated with longer AGD in male infants (Barrett et al., 2014) and fetuses (Fowler et al., 2016) . In our study, the AGD was not associated with maternal age or smoking during pregnancy but was longer in the boys who were current passive smokers. Further research is warranted to explore a possible causal explanation for this association.
Only three cross-sectional studies have investigated the relationship between AGD and male reproductive hormone levels, and their results are contradictory (Eisenberg et al., 2012a; Parra et al., 2016; Zhou et al., 2016) . Thus, AGD was not associated with total and free testosterone, inhibin B, FSH, LH, estradiol, or sex hormone-binding globulin levels in Spanish university students (Parra et al., 2016) , but it was associated with lower estradiol levels and higher testosterone/estradiol ratio in healthy young Chinese men, whose AGD was measured from the cephalad insertion of the penis to the center of the anus (Zhou et al., 2016) . In the USA, Eisenberg et al. (2012a) found a positive association between AGD and serum testosterone levels in men attending an andrology clinic. In a study of male newborns in China, the AGD was associated with increased levels of thyroid hormones in cord serum . We found no significant association between AGD and serum hormone levels, possibly due to the relatively small number of boys for whom hormone data were available (187 of 279), especially among those in Tanner stage >G1 (28 of 57 boys). However, the reasons for the controversial findings to date are not yet clear, but they could be due to differences in studied age ranges, residual confounding, or even ethnic factors.
As a measure of reduced androgenization during fetal life, shortened AGD in males may be related to genital tract malformations. In fact, reduced AGD has been associated with cryptorchidism and hypospadias in human fetuses and infants (Swan et al., 2005; Hsieh et al., 2008 Hsieh et al., , 2012 Jain & Singal, 2013; Thankamony et al., 2014; Gilboa et al., 2017) , indicating that both reduced AGD and male genital anomalies may have a common etiology, namely abnormal androgen signaling in utero (Welsh et al., 2008; van den Driesche et al., 2012) . Cryptorchidism at birth or follow-up was not associated with AGD in early puberty in the present study. One explanation of the null association with undescended testis at 9-11 years old may be that some of the boys born with cryptorchidism may have undergone surgical correction or may have experienced late spontaneous testicular descent or testicular retraction; furthermore, no data are available on the AGD of participants at birth. Nonetheless, given that the AGD is primarily determined in utero, their AGD at birth could be expected to correlate with perineal measurements later in life.
Besides the lack of information on neonatal AGD, the age of the boys under study (9-11 years) might not be the most suitable for investigating the association between AGD and pubertal development. In fact, only two boys were in Tanner stage G3. Moreover, as noted above, the association observed between AGD and testicular growth but not Tanner stage may be explained by the fact that pubic hair growth was not graded separately from genital development. It should also be taken into account that Prader's orchidometer may be less accurate than scrotal ultrasound to measure testicular volume in children (Diamond et al., 2000; Sotos & Tokar, 2017) , and the correlation of volumes with Tanner stages of genital development may not be useful due to an overlapping of these values (Sotos & Tokar, 2017) . Thus, the partial disagreement between increased testicular volume (>3 mL) and Tanner stage >G1 may also be partly attributable to some degree of misclassification of testicular volume. Despite these limitations, we contribute data on AGD measurements from a relatively large sample of boys (>250) in an age range that has not previously been investigated. We also provide the first published report on the relationship between AGD and children's reproductive outcomes. This is a population-based study in a demographically and ethnically homogeneous group of boys, which might be seen as an additional strength. Finally, AGD measurement from the anus to the posterior base of the scrotum has been shown to be consistent and adequate for epidemiological studies , yielding a low interobserver variability (Dean & Sharpe, 2013; Papadopoulou et al., 2013) .
CONCLUSIONS
AGD is considered a useful marker for testicular function and reproductive potential in adult men (Eisenberg et al., 2011 (Eisenberg et al., , 2012b Mendiola et al., 2011 Mendiola et al., , 2015 Eisenberg & Lipshultz, 2015) . The present results suggest that longer AGD in peripubertal boys is associated with increased testicular volume, but it remains unknown whether AGD predicts testicular size at puberty or is related to the onset of sexual maturation. Population studies of AGD are limited to measurements in infants and adults, and this study represents the first report on the relationship between AGD and reproductive outcomes in peripubertal boys. Further population studies are warranted on AGD as a predictor of sexual and reproductive health outcomes later in life. early Stimulation Unit (USEP) of the San Cecilio University Hospital (Granada, Spain). The authors gratefully acknowledge editorial assistance provided by Richard Davies. This study was supported in part by research grants from the European Union 
